Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease

被引：0
|
作者：
Hassan Saadati
Hamid Reza Baradaran
Goodarz Danaei
Afshin Ostovar
Farzad Hadaegh
Leila Janani
Ewout W. Steyerberg
Davood Khalili
机构：
[1] Iran University of Medical Sciences,Department of Epidemiology, School of Public Health
[2] Medical Sciences and Nutrition University of Aberdeen,Ageing Clinical and Experimental Research Team, Institute of Applied Health Sciences, School of Medicine
[3] Iran University of Medical Sciences,Endocrine Research Center, Institute of Endocrinology and Metabolism
[4] Harvard TH Chan School of Public Health,Department of Global Health and Population and Department of Epidemiology
[5] Tehran University of Medical Sciences,Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[6] Research Institute for Endocrine Sciences,Prevention of Metabolic Disorders Research Center
[7] Shahid Beheshti University of Medical Sciences,Department of Biostatistics, School of Public Health
[8] Iran University of Medical Sciences,Department of Biomedical Data Sciences
[9] Leiden University Medical Center,Department of Public Health
[10] Erasmus MC,Department of Biostatistics and Epidemiology
[11] Research Institute for Endocrine Sciences,undefined
[12] Shahid Beheshti University of Medical Sciences,undefined
来源：
BMC Medical Informatics and Decision Making | / 20卷
关键词：
Preferences; Statins; Benefit harm outcomes; Primary prevention; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Primary care providers' physical activity counseling and referral practices and barriers for cardiovascular disease prevention
    Omura, John D.
    Bellissimo, Moriah P.
    Watson, Kathleen B.
    Loustalot, Fleetwood
    Fulton, Janet E.
    Carlson, Susan A.
    PREVENTIVE MEDICINE, 2018, 108 : 115 - 122
  • [22] CARDIOVASCULAR GENETIC RISK TESTING FOR TARGETING STATIN THERAPY IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE: A COST-EFFECTIVENESS ANALYSIS
    Jarmul, Jamie A.
    Pletcher, Mark J.
    Earnshaw, Stephanie
    Weinberger, Morris
    Jonas, Daniel
    Avery, Christy
    Lich, Kristen Hassmiller
    Wheeler, Stephanie
    Pignone, Michael
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S133 - S134
  • [23] Predictors of cholesterol treatment discussions and statin prescribing for primary cardiovascular disease prevention in community health centers
    Karmali, Kunal N.
    Lee, Ji-Young
    Brown, Tiffany
    Persell, Stephen D.
    PREVENTIVE MEDICINE, 2016, 88 : 176 - 181
  • [24] Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care
    Virani, Salim S.
    Akeroyd, Julia M.
    Ramsey, David J.
    Deswal, Anita
    Nasir, Khurram
    Rajan, Suja S.
    Ballantyne, Christie M.
    Petersen, Laura A.
    POPULATION HEALTH MANAGEMENT, 2018, 21 (03) : 209 - 216
  • [25] Who Benefits From Taking a Statin, and When? On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease
    Leening, Maarten J. G.
    CIRCULATION, 2020, 142 (09) : 838 - 840
  • [26] Health promotion and disease prevention in general practice and primary care: a scoping study
    Peckham, Stephen
    Hann, Alison
    Kendall, Sally
    Gillam, Steve
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2017, 18 (06): : 529 - 540
  • [27] Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care
    Weinehall, L
    Hallgren, CG
    Westman, G
    Janlert, U
    Wall, S
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 1998, 16 (03) : 171 - 176
  • [28] Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study
    Hill, Sophie
    Spink, Janet
    Cadilhac, Dominique
    Edwards, Adrian
    Kaufman, Caroline
    Rogers, Sophie
    Ryan, Rebecca
    Tonkin, Andrew
    BMC PUBLIC HEALTH, 2010, 10
  • [29] Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study
    Sophie Hill
    Janet Spink
    Dominique Cadilhac
    Adrian Edwards
    Caroline Kaufman
    Sophie Rogers
    Rebecca Ryan
    Andrew Tonkin
    BMC Public Health, 10
  • [30] Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease A Cost-Effectiveness Analysis
    Jarmul, Jamie
    Pletcher, Mark J.
    Lich, Kristen Hassmiller
    Wheeler, Stephanie B.
    Weinberger, Morris
    Avery, Christy L.
    Jonas, Daniel E.
    Earnshaw, Stephanie
    Pignone, Michael
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2018, 11 (04):
12345